Advancements-in-computer-aided-drug-design|OMICS International|Drug Designing: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Advancements In Computer Aided Drug Design

While surgery, radiotherapy and chemotherapy are able to cure many cancers, new approaches are required to improve radical curative therapy. A possible route is to utilize the latest achievements made in research on the immunology and genetics of cancer. Cancer immunotherapy, or the manipulation of the naturally occurring oncolytic immune reaction, is based on the observation that both in animals and humans neoplastic cell antigens stimulate the onset of specific humoral and cellular antibodies. Tarro et al. demonstrated that when TLP is extracted from a tumor, purified in the laboratory, and reintroduced into the patient’s body, it boosts the immune system’s cancer responsive capabilities. Vs Tarro G, Tumor Liberated Protein (TLP) from lung cancer and perspectives for immunotherapy. Drug Designing Open Access strives to release issues quarterly and is adamant to publish new findings related to the field of in-silico drug designing, high-throughput screening, drug targets, and structure-activity relationships.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on January, 2021